| Nov 13, 2025 |
Nov 17, 2025 |
Powell Fred M
|
CFO |
Neutral |
47.5
|
-65,000
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
Wadlinger Mary E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
Oliger Christy J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
Noble James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
Kiener Peter A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
Backstrom Jay T.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
WILSON KAREN J
|
Director |
Neutral |
47.5
|
-10,000
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
Dhingra Kapil
|
Director |
Neutral |
47.5
|
-30,000
|
-100.00%
|
✗
|
- |
| Nov 13, 2025 |
Nov 17, 2025 |
HURLY STEPHEN A
|
CEO |
Neutral |
47.5
|
-5,000
|
-100.00%
|
✗
|
- |
| Oct 16, 2025 |
Oct 20, 2025 |
Cooperatieve Gilde Healthcare IV U.A.
|
10% Owner |
Sell |
17.5
|
-2,871,370
|
-24.14%
|
✗
|
$4.2M |
| Oct 13, 2025 |
Oct 15, 2025 |
Cooperatieve Gilde Healthcare IV U.A.
|
10% Owner |
Sell |
20.0
|
-475,027
|
-3.05%
|
✗
|
$718.7K |
| Oct 8, 2025 |
Oct 10, 2025 |
Cooperatieve Gilde Healthcare IV U.A.
|
10% Owner |
Sell |
22.5
|
-126,992
|
-2.34%
|
✗
|
$197.9K |
| Sep 19, 2025 |
Sep 23, 2025 |
Versant Venture Capital VI, L.P.
|
10% Owner |
Sell |
17.5
|
-2,903,403
|
-100.00%
|
✗
|
$4.1M |
| Sep 16, 2025 |
Sep 18, 2025 |
Versant Venture Capital VI, L.P.
|
10% Owner |
Sell |
17.5
|
-1,684,434
|
-36.72%
|
✗
|
$2.5M |
|
Apr 8, 2025 |
Cooperatieve Gilde Healthcare IV U.A.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
WILSON KAREN J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Wadlinger Mary E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Noble James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Kiener Peter A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Backstrom Jay T.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Dhingra Kapil
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Powell Fred M
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Morris Charles Q
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
Oliger Christy J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 13, 2025 |
Feb 18, 2025 |
HURLY STEPHEN A
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Feb 6, 2025 |
Versant Venture Capital VI, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
WILSON KAREN J
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Wadlinger Mary E.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Oliger Christy J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Noble James
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Kiener Peter A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Backstrom Jay T.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Dhingra Kapil
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Morris Charles Q
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
Powell Fred M
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 2, 2025 |
HURLY STEPHEN A
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |